AbbVie Inc. Files 8-K on Financial Operations
Ticker: ABBV · Form: 8-K · Filed: Jul 31, 2025 · CIK: 1551152
| Field | Detail |
|---|---|
| Company | Abbvie Inc. (ABBV) |
| Form Type | 8-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, debt, operations
Related Tickers: ABBV
TL;DR
AbbVie dropped an 8-K on 7/31 detailing debt like 0.75% notes due '27. Looks like business as usual.
AI Summary
On July 31, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior notes, such as the 0.750% Senior Notes due 2027 and 2.125% Senior Notes due 2028, indicating ongoing financial activities and debt management.
Why It Matters
This filing provides insight into AbbVie's current financial standing and debt structure, which is crucial for investors assessing the company's stability and future prospects.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting financial information and does not indicate any unusual or negative events.
Key Players & Entities
- AbbVie Inc. (company) — Registrant
- 0.750% Senior Notes due 2027 (dollar_amount) — Debt instrument
- 2.125% Senior Notes due 2028 (dollar_amount) — Debt instrument
- July 31, 2025 (date) — Report date
FAQ
What is the primary purpose of this 8-K filing by AbbVie Inc.?
The primary purpose of this 8-K filing is to report on AbbVie Inc.'s results of operations and financial condition as of July 31, 2025.
What specific financial instruments are mentioned in the filing related to AbbVie's debt?
The filing mentions several senior notes, including the 0.750% Senior Notes due 2027, 2.125% Senior Notes due 2028, 2.625% Senior Notes due 2028, 2.125% Senior Notes due 2029, and 1.250% Senior Notes due 2031.
On what date was this 8-K report filed?
This 8-K report was filed as of July 31, 2025.
What is AbbVie Inc.'s state of incorporation and fiscal year end?
AbbVie Inc. is incorporated in Delaware and its fiscal year ends on December 31.
What is the SEC file number for AbbVie Inc.'s 8-K filing?
The SEC file number for this 8-K filing is 001-35565.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding AbbVie Inc. (ABBV).